Users online: 2840    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacology and Pharmacodynamics
Year : 2017, Volume : 9, Issue : 1
First page : ( 10) Last page : ( 12)
Print ISSN : 0975-4407. Online ISSN : 2321-5836.
Article DOI : 10.5958/2321-5836.2017.00002.7

Survey on antidiabetic drugs

Raut Indrayani D.*, Kakade Akshada N., Snehal Jadhav, Priyanka Jadhav, Amruta Kabir

Rajarambapu College of Pharmacy, Kasegaon, (MS), India

*Corresponding Author E-mail: indrayaniraut7363@rediffmail.com

Online published on 26 April, 2017.


Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or alternatively, when the body cannot effectively use the insulin it produces. According to the Indian Council of Medical Research-Indian Diabetes study (ICMR), a national diabetes study, India currently has 62.4 million people with diabetes. A Home survey of various antidiabetic drugs was carried out by visiting individual patients home in the region of Vategaon (Walva). Currently, there are five distinct classes of hypoglycemic agents available, each class displaying unique pharmacologic properties. These classes are the sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha glucosidase inhibitors. The objective of the study was to find out the most frequently used drug for the Antidiabetic for the diabetes treatment. Therefore, this study was carried out to find the current prescribing pattern of anti-diabetic drugs and efficacy of these drugs in maintaining adequate glycemic control in diabetic patients in vategaon region. The study revealed that the Biguanide have been followed by the sulphonylureas which were prescribed in 32% prescriptions followed by 6% was Thiazolidinedione and then 8% α glucosidase inhibitor.



Diabetes, survey, Antidiabetic drugs.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
446,702,186 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.